-
05.23.2022 Convocation Notice of the 76th Ordinary General Meeting of Shareholders
（206KB）
読む Convocation Notice of the 76th Ordinary General Meeting of Shareholders
-
05.13.2022 Seikagaku announces Acquisition of Treasury Stocks
（65KB）
-
05.13.2022 Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
（191KB）
読む Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
-
05.13.2022 Seikagaku Initiates a Phase III Clinical Study for SI-614, a Therapeutic Agent for Dry Eye, in the U.S.
（69KB）
Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.
-
05.17.2022 Presentation Material for the Briefing on FY2021 Financial Results
読む Presentation Material for the Briefing on FY2021 Financial Results
-
05.13.2022 Seikagaku announced the financial results for the Fiscal Year ended March, 2022
読む Seikagaku announced the financial results for the Fiscal Year ended March, 2022
-
04.01.2022 Seikagaku will announce the financial results for the Fiscal Year ended March 31, 2022 at 16:00 on May 13, 2022
-
02.08.2022 Seikagaku announced the financial results for the Third Quarter of the Fiscal Year ending March 31, 2022
